KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Return on Invested Capital (2017 - 2025)

Acadia Pharmaceuticals (ACAD) has 9 years of Return on Invested Capital data on record, last reported at 0.07% in Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 23.0% year-over-year to 0.07%; the TTM value through Sep 2025 reached 0.07%, down 23.0%, while the annual FY2025 figure was 0.3%, 22.0% up from the prior year.
  • Return on Invested Capital reached 0.07% in Q3 2025 per ACAD's latest filing, up from 0.05% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.3% in Q3 2024 and bottomed at 0.46% in Q2 2021.
  • Average Return on Invested Capital over 5 years is 0.06%, with a median of 0.02% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: soared 39bps in 2021, then dropped -23bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.06% in 2021, then tumbled by -73bps to 0.11% in 2022, then surged by 70bps to 0.03% in 2023, then soared by 255bps to 0.05% in 2024, then surged by 40bps to 0.07% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.07% in Q3 2025, 0.05% in Q1 2025, and 0.05% in Q4 2024.